DNLI
Denali Therapeutics Inc
21.60$
+5.5%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.01 | -11.26 | -5.12 | 0.54 | -1.59 | 3.69 | -1.74 | -1.95 | -2.61 | -2.11 | -2.35 | |
| 0.04 | 0.23 | 0.21 | 0.08 | 0.08 | 0.08 | 0.07 | 0.08 | 0.12 | 0.05 | 0.08 | |
| 0.16 | 0.46 | 0.29 | 0.20 | 0.40 | 0.45 | 0.70 | 0.80 | 0.79 | 0.63 | 0.57 | |
| 0.40 | 1.33 | 0.35 | 0.20 | 0.40 | 0.45 | 0.75 | 0.76 | – | – | – | |
| 0.14 | 0.67 | 0.22 | 0.68 | 0.03 | 2.56 | -0.17 | -0.19 | -2.11 | 0.10 | 0.00 | |
| 1.02 | 0.95 | 0.19 | 0.04 | 0.19 | 0.03 | 0.07 | 0.14 | 0.09 | 0.10 | 0.05 | |
| -1.02 | -34.09 | -2.75 | -3.10 | 1.54 | -5.53 | -0.18 | -1.13 | 1.81 | -0.54 | 1.45 | |
| 14.59 | 46.77 | 19.80 | 0.03 | 0.06 | 1.90 | 0.16 | – | – | – | – | |
| 1.66 | – | – | – | – | – | – | 0.00 | 0.00 | -0.20 | -0.05 | |
| 16.25 | 46.77 | 19.80 | 1.05 | 0.06 | 5.63 | 0.16 | 2.47 | 0.13 | 2.94 | 1.08 | |
| 10.22 | 1.42 | 11.93 | -1.51 | 0.02 | 3.79 | -1.76 | -0.60 | -0.66 | 0.29 | 0.18 | |
| -6.03 | -12.22 | -5.31 | 0.50 | -1.77 | 3.67 | -1.81 | -2.09 | -2.70 | -2.21 | -2.41 |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.